[1] Taspinar M,Aydos S,Sakiragaoglu O,et al.Impact of genetic variations of the CYP1A1,GSTT1,and GSTM1 genes on the risk of coronary artery disease[J].DNA Cell Biol,2012,31(2):211-218.
[2] 陈瑗,周玫.氧化应激-炎症在动脉粥样硬化发生发展中作用研究的新进展[J].中国动脉硬化杂志,2008,16(10):757-762.
[3] Gensini GG.A more meaningful scoring system for determining the severity of comnary heart disease[J].Am J Cardiol,1983,51(3):606.
[4] 唐蕊,李海涛,马文君,等.正常高值血压患者血清脂质过氧化水平变化及其意义[J].中华高血压杂志,2009,19(4):318-321.
[5] 李淑娟,李春更,侯勇,等.大黄酚抗衰老作用研究进展[J].河北北方学院学报:医学版,2009,26(1):69-71.
[6] Armstrong JS,Steinauer KK,Hornung B,et al.Role of glutathione depletion and reactive oxygen spcies generation inapoptotic signaling in a human B lymphoma cell line[J].Cell Death Differ,2002,9(3):252-263.
[7] 李斌晨,吴明营,蒙革,等.还原型谷胱甘肽临床研究及应用进展[J].中国医疗前沿,2008,3(6):9-10.
[8] Parthasarathy S,Raghavamenon A,Garelnabi MO,et al.Oxidized low-density lipoprotein[J].Methods Mol Biol,2010,610:403-417.
[9] Sun Y,Qi G,Gao Y,et al.Effect of different loading doses of atorvastatin on percutaneous coronary intervention for acute coronary syndromes[J].Can J Cardiol,2010,26(9):481-485.
[10] 许娟,韩浩,张笠.还原型谷胱甘肽对慢性阻塞性肺疾病急性加重期患者氧化应激的影响[J].国际检验医学杂志,2011,32(5):565-566.
[11] 张帆,吴赛珠,张莉,等.辛伐他汀对稳定型心绞痛患者血浆SOD、MDA及8-异构前列腺素F2a的影响[J].南方医科大学学报,2010,30(11):2646-2648.
[12] 方毅民,董炳庆.还原型谷胱甘肽对急性心肌梗死再灌注的疗效观察[J].中国全科医学2005,12(18):54-55.
[13] Fabian E,Bogner M,Elmadfa I.Age-related modification of antioxidant enzyme activities in relation to cardiovascular risk factors[J].Eur J Clin Invest,2012,42(1):42-48.
[14] Felice F,Lucchesi D,di Stefano R,et al.Oxidative stress in response to high glucose levels in endothelial cells and in endothelial progenitor cells:evidence for differential glutathione peroxidase-1 expression[J].Microvasc Res,2010,80(3):332-338.
[15] 樊建备,朱莉,殷屹岗.冠心病患者血浆谷胱甘肽氧化还原状态的临床意义[J].临床心血管病杂志,2010,26(4):54-57.